Independent Double Check required for oral hormonal antineoplastics

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org. 

2 posts / 0 new
Log in or register to post comments
Last post
Fri, 12/18/2015 - 15:16
#1
Karen Thompson
Karen Thompson's picture
Offline
Last seen: 10 months 2 weeks ago
Joined: 05/03/2009 - 02:30
Independent Double Check required for oral hormonal antineoplastics

Do any facilities require an independent double check for all oral chemo EXCEPT for hormonal antineoplastics (e.g. Megace, tamoxifen)? If so, what was your evidence/rationale? We are considering excluding hormonal antineoplastics from our IDC requirement. Our EHR is currently programmed to require a dual sign on ALL meds with an AHFS therapeutic class of "antineoplastic". I'd like to have evidence that giving too much of a hormonal antineoplastic will not harm the patient like other oral chemotherapies could...

Top